Allo-immune membranous nephropathy and recombinant aryl sulfatase replacement therapy: a need for tolerance induction therapy.
J Am Soc Nephrol. 2014 Apr;25(4):675-80. doi: 10.1681/ASN.2013030290. Epub 2013 Nov 21.
J Am Soc Nephrol. 2014.
PMID: 24262793
Free PMC article.
ERT was resumed 8 weeks after starting immunosuppressive therapy without inducing a rebound of antibody titer or an increase in proteinuria. We conclude that the allo-immune response to the recombinant rhASB caused the nephropathy. Considering the critical re …
ERT was resumed 8 weeks after starting immunosuppressive therapy without inducing a rebound of antibody titer or an increase in proteinuria. …